Arthritis induced by interleukin-1 is dependent on the site and frequency of intraarticular injection

Clinical Immunology and Immunopathology

Volumn 55, Issue 3, 1990, Pages 382-400

  Chandrasekhar, Srinivasan ^a   Harvey, Anita K ^a   Hrubey, Pamela S ^a   Bendele, Alison M ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; PROTEOGLYCAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; CARTILAGE CELL; HISTOLOGY; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; RAT;

AGING; ANIMAL; ANKLE JOINT; ARTHRITIS; BODY WEIGHT; INJECTIONS, INTRA-ARTICULAR; INTERLEUKIN-1; KNEE JOINT; MALE; PROTEOGLYCANS; RATS; RATS, INBRED LEW;

EID: 0025334020     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1016/0090-1229(90)90126-B     Document Type: Article

References (54)

1. The pathogenesis of osteoarthritis
2. Aspects of the cell biology of the rheumatoid synovial lesion
3. Rheumatoid arthritis: Evolving concepts of pathogenesis and treatment
4. Rheumatoid arthritis: A disease of T lymphocyte/macrophage immunoregulation
5. Pathogenesis of rheumatoid arthritis
6. Biology of interleukin 1
7. There is more than one interleukin 1
8. The role of tumor-necrosis factor and interleukin-1 in the immunoinflammatory response
9. Interleukin-1 and T-cell activation
10. Interleukin-1
11. Interleukin-1, a potential regulator of fibroblast proliferation
12. Collagenase production by rheumatoid synovial cells
13. Effect of synovial tissue on the breakdown of articular cartilage in organ culture
14. Synthesis of collagenase and neutral proteases by articular chondrocytes: Stimulation by a macrophage-derived factor
15. A cartilage catabolic factor from synovium
16. Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin-1)
17. In vitro activation of human chondrocytes and synoviocytes by a human interleukin-1-like factor
18. Macrophage secretory products and connective tissue remodeling: Role of macrophage enzymes and of ‘matrix regulatory monokines’
19. The role of interleukin-1 in the pathogenesis of rheumatoid arthritis
20. Cloning and expression of murine interleukin-1 in Eschericia coli
21. Nucleotide sequence of human monocyte interleukin-1 precursor cDNA
22. Cloning, sequence and expression of two distinct human interleukin 1 complementary cDNA
23. Cloning and characterization of the cDNAs for human and rabbit interleukin-1 precursor
24. Detection and characterization of high affinity plasma membrane receptors for human interleukin 1
25. Interleukin 1 and interleukin 1 bind to the same receptor on T cells
26. Properties of a specific interleukin 1 (IL-1) receptor on human Epstein-Barr virus-transformed B lymphocytes: Identity of the receptor for IL-1A and IL-B
27. Production of intracellular and extracellular interleukin-1 (IL-1) by human monocytes
28. Intracellular localization of human monocyte associated interleukin-1 (IL-1) activity and release of biologically active IL-1 from monocytes by trypsin and plasmin
29. In vivo administration with IL-1 accelerates the development of collagen-induced arthritis in mice
30. Exacerbation of arthritis by IL-1 in rat joints previously injured by peptidoglycan-polysaccharide
31. IL-1 treatment enhances the development of type II collagen-induced arthritis in several different mouse strains
32. Interleukin-1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint
33. In vivo studies of articular tissue damage mediated by catabolin/interleukin-1
34. High level expression of human IL-1 and variants from a synthetic gene
35. Mouse lymphotoxin and tumor necrosis factor: Structural analysis of the cloned genes, physical linkage, and chromosomal position
36. Studies on the purification and structure-functional relationships of murine lymphocyte activating factor (interleukin-1)
37. The inhibitory effect of polymyxin B on endotoxin-induced endogenous pyrogen production
38. Interleukin-1 induced alterations in proteoglycan metabolism and matrix assembly
39. Hereditary joint disorder in progressive ankylosis (ank/ank) mice
40. Intraneural substance P contributes to the severity of experimental arthritis
41. An analysis of the American rheumatism Association citeria for rheumatoid arthritis
42. Isolation of an interleukin-1-like factor from human joint effusions
43. Interleukin-1 activity in the synovial fluid of patients with rheumatoid arthritis
44. Enhanced interleukin-1 generation by monocytes in vitro is temporarily linked to an early event in the onset or exacerbation of rheumatoid arthritis
45. Expression of IL-1 gene in human and bovine chondrocytes A mechanism for autocrine control of cartilage matrix degradation
46. Synthesis of interleukin-1-like activity by normal rat chondrocytes in culture
47. Purification and partial sequence of human osteoclast activating factor: Identity with interleukin 1β
48. Identification of a high-affinity receptor for native human interleukin-1β and interleukin-1α on normal human lung fibroblasts
49. Induction of interleukin-1 receptors on chondrocytes by fibroblast growth factor: A possible mechanism for modulation of interleukin-1 activity
50. Detection and characterization of high affinity plasma membrane receptors for human interleukin-1
51. Pig interleukin-1 (catabolin) induces resorption of cartilage proteoglycans and prevents the synthesis of proteoglycan and collagen
52. Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses
53. Characteristics of tumor necrosis factor production in rheumatoid arthritis
54. Identification of a membrane-associated interleukin-1 in macrophages